Cargando…

HLA B(∗)5701 status, disease progression, and response to antiretroviral therapy

OBJECTIVE: In addition to hypersensitivity reactions to abacavir, HLA B(∗)5701 has been associated with slow or nonprogression of HIV infection. We explored the effect of HLA B(∗)5701 on CD4(+) cell count and viral load in untreated patients and on responses to nonabacavir-containing combination ant...

Descripción completa

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2013
Materias:	Clinical Science: Concise Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814941/ https://www.ncbi.nlm.nih.gov/pubmed/23921616 http://dx.doi.org/10.1097/01.aids.0000432613.95455.71

Ejemplares similares

HLA-B*5701 testing to predict abacavir hypersensitivity
por: Ma, Joseph D., et al.
Publicado: (2010)

Risk of Mycobacterium tuberculosis transmission in an antiretroviral therapy clinic
por: Mzembe, Themba, et al.
Publicado: (2018)

Frequency of HLA B*5701 allele carriers in abacavir treated-HIV infected patients and controls from northeastern Brazil
por: Crovella, Sergio, et al.
Publicado: (2011)

Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapy
por: Jose, Sophie, et al.
Publicado: (2014)

Dolutegravir is not associated with weight gain in antiretroviral therapy experienced geriatric patients living with HIV
por: Guaraldi, Giovanni, et al.
Publicado: (2021)

Inflammatory biomarkers prior to antiretroviral therapy as prognostic markers of 12-month mortality in South Africa and Uganda
por: Siedner, Mark J., et al.
Publicado: (2019)

Influence of HLA-B*5701 on 20 year survival rate among patients living with HIV
por: Aksak-Wąs, Bogusz Jan, et al.
Publicado: (2021)

Plasma galectin-9 as a predictor of adverse non-AIDS events in persons with chronic HIV during suppressive antiretroviral therapy
por: Premeaux, Thomas A., et al.
Publicado: (2021)

Prevalence of HLA-B*5701 and Its Relationship with Abacavir Hypersensitivity Reaction in Iranian HIV-Infected Patients
por: Baniasadi, Shadi, et al.
Publicado: (2016)

Correction: Influence of HLA-B*5701 on 20 year survival rate among patients living with HIV
por: Aksak-Wąs, Bogusz Jan, et al.
Publicado: (2022)

Prevalence of the HLA-B*5701 Allele and Abacavir Hypersensitivity in Saudi HIV Patients: A Multicenter Study
por: Alsaeed, Ali, et al.
Publicado: (2023)

Protective Effect of HLA-B*5701 and HLA-C -35 Genetic Variants in HIV-Positive Caucasians from Northern Poland
por: Leszczyszyn-Pynka, Magdalena, et al.
Publicado: (2015)

Baseline CD4(+) T Cell Counts Correlates with HIV-1 Synonymous Rate in HLA-B*5701 Subjects with Different Risk of Disease Progression
por: Norström, Melissa M., et al.
Publicado: (2014)

Dosing antiretroviral medication when crossing time zones: a review
por: Lewis, Joseph M., et al.
Publicado: (2016)

Correction: Baseline CD4+ T Cell Counts Correlates with HIV-1 Synonymous Rate in HLA-B*5701 Subjects with Different Risk of Disease Progression
Publicado: (2014)

Idiopathic/Simple Onycholysis: Response to Combination Topical Therapy
por: Grover, Chander, et al.
Publicado: (2022)

Cost impact of prospective HLA-B*5701-screening prior to abacavir/lamivudine fixed dose combination use in Germany
por: Wolf, E, et al.
Publicado: (2010)

Alzheimer’s disease and progressive supranuclear palsy share similar transcriptomic changes in distinct brain regions
por: Wang, Xue, et al.
Publicado: (2022)

Group B Streptococcus in the urine in nonpregnant adults: Disease or distraction?
por: Mongilardi, Nicole, et al.
Publicado: (2022)

Conjunctival Ulcers in Behcet's Disease and Response to Colchicine
por: Kaur, Ishmeet, et al.
Publicado: (2020)

Abacavir Hypersensitivity Reaction Reporting Rates During a Decade of HLA‐B*5701 Screening as a Risk‐Mitigation Measure
por: Stainsby, Chris M., et al.
Publicado: (2018)

Response of Acitretin in Greither's Disease: A Rare Case Report
por: Supekar, Bhagyashree B., et al.
Publicado: (2020)

Incidence of Disease Flare After BNT162b2 Coronavirus Disease 2019 Vaccination in Patients With Rheumatoid Arthritis in Remission
por: Bixio, Riccardo, et al.
Publicado: (2021)

Altered cytokine expression by macrophages from HLA-B27-positive spondyloarthritis patients without evidence of endoplasmic reticulum stress
por: Ambarus, Carmen A, et al.
Publicado: (2018)

Progressive Symmetric Erythrokeratodermia with Overlying Psoriasis as Wolf's Isotopic Phenomenon: A Case Report
por: Ahmed, Ghazal, et al.
Publicado: (2022)

Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adults
por: Kasirye, Ronnie P., et al.
Publicado: (2017)

HIV and urethritis: time required for antiretroviral therapy to suppress HIV in semen
por: Matoga, Mitch, et al.
Publicado: (2023)

HLA-associated polymorphisms in the HIV-2 capsid highlight key differences between HIV-1 and HIV-2 immune adaptation
por: de Silva, Thushan I., et al.
Publicado: (2018)

Diminishing returns, increasing risks: Impact of antibiotic duration of therapy on respiratory bacterial isolates in hospitalized patients during the coronavirus disease 2019 (COVID-19) pandemic
por: Li, Catherine, et al.
Publicado: (2021)

Rapid response to a coronavirus disease 2019 (COVID-19) outbreak in a psychiatry hospital—Kanazawa City, Japan, March to April 2020
por: Kato, Hirofumi, et al.
Publicado: (2022)

Understanding healthcare workers’ knowledge and attitudes regarding the coronavirus disease 2019 (COVID-19) vaccine: Overcoming gaps to improve public health response
por: Mo, James, et al.
Publicado: (2022)

Head circumferences of children born to HIV-infected and HIV-uninfected mothers in Zimbabwe during the preantiretroviral therapy era
por: Evans, Ceri, et al.
Publicado: (2016)

Placental transfer of anti-group B Streptococcus immunoglobulin G antibody subclasses from HIV-infected and uninfected women to their uninfected infants
por: Le Doare, Kirsty, et al.
Publicado: (2016)

Patient outcomes following home-based outpatient parenteral antimicrobial therapy and facility-based outpatient parenteral antimicrobial therapy: a systematic review and meta-analysis
por: Hasegawa, Shinya, et al.
Publicado: (2023)

Epidermal hepcidin is required for neutrophil response to bacterial infection
por: Malerba, Mariangela, et al.
Publicado: (2019)

High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for integrase strand transfer inhibitor salvage therapy
por: Huik, Kristi, et al.
Publicado: (2022)

Antifungal Efficacy of Amphotericin B against Dermatophytes and its Relevance in Recalcitrant Dermatophytoses: A Commentary
por: Sinha, Surabhi, et al.
Publicado: (2018)

Topical efinaconazole: A sequential combination therapy with oral terbinafine for refractory tinea unguium
por: Noguchi, Hiromitsu, et al.
Publicado: (2021)

Clinical outcomes following dalbavancin administration in patients with barriers to outpatient parenteral antimicrobial therapy
por: Tuan, Jessica J., et al.
Publicado: (2022)

Using the COM-B model to identify barriers to and facilitators of evidence-based nurse urine-culture practices
por: Advani, Sonali D., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qq97juhh3okqd40ic2o0mehk4k